Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (387)
- Scheduling (national classification system) (168)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
768 result(s) found, displaying 301 to 325
-
Corporate reportsThe Freedom of Information disclosure log gives access to information we've released in response to an FOI request.
-
Corporate reportsWe thank respondents who provided a submission in response to the public consultation paper proposed refinements to the regulation of personalised medical devices.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Corporate reportsThe TGA 2020-21 Annual Performance Statistics Report has now been published.
-
Scheduling submissionsPublic submissions made in response to the public consultation on proposed amendments to the Poisons Standard - March 2021 ACMS/ACCS meetings
-
Corporate reportsIn the past 12-18 months, the TGA has implemented a number of changes in an effort to increase and improve post-market monitoring and surveillance activities.
-
Corporate reportsThe guidelines set out the criteria which must be met for any additional manufacturing sites to be included as secondary sites on new or existing manufacturing licences.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closed: 11 November 2021
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement available.
-
Scheduling decisions (final)Notice of final decision to amend the Poisons Standard in relation to nitrous oxide - Joint ACMS-ACCS#27 (March 2021)
-
Meeting statementsA meeting statement is now available for the last Advisory Committee on Complementary Medicines meeting
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Corporate reports2020/21 Therapeutic Goods Advertising Compliance Annual Report has been published
-
Corporate reportsSubmissions published and summarised as part of a consultation on clarifying the regulation of 'residual activity' claims for disinfectants.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (final)Notice of the New Chemical Entities that are to be scheduled in the Poisons Standard that comes into effect on 1 October 2021.
-
Meeting statementsA meeting of the Therapeutic Goods Advertising Consultative Committee was held on 23 August 2021.
-
Corporate reportsThis document contains practical information produced by a team from the University of Wollongong, based on their years of practical research on nicotine vaping products.
-
Corporate reportsPractical flowcharts produced by the University of Wollongong based on their years of practical research on nicotine vaping products
-
Corporate reportsOutcomes following review of consultation submissions
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Corporate reportsThe number of women in Australia who have had transvaginal mesh implants and related matters.